(Q37167142)

18 August 2017

JC viremia in natalizumab-treated patients with multiple sclerosis (English)

1 reference

18 August 2017

0 references

0 references

Eugene O Major

1

1 reference

18 August 2017

Elliot Frohman

series ordinal

2

1 reference

18 August 2017

Daniel Douek

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 June 2013

1 reference

The New England Journal of Medicine

18 August 2017

1 reference

18 August 2017

368

1 reference

18 August 2017

23

1 reference

18 August 2017

2240-2241

1 reference

Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771634

Risk of natalizumab-associated progressive multifocal leukoencephalopathy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771634

JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771634

Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771634

27 June 2018

Reply: To PMID 21246607.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23738566

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1056/NEJMC1214233

1 reference

18 August 2017

1 reference

18 August 2017

1 reference